[1] 魏矿荣,余元龙,杨有业,等. 中国鼻咽癌流行概况[J]. 实用预防
医学,2010,17(4):828-830.
[2] 邓卓霞,司勇锋,陶仲强. 鼻咽癌病因研究及早期诊断与治疗[J].
国际耳鼻咽喉头颈外科杂志, 2016,40(3):173-177.
[3] 邱厚匡,姚亚超,李磊,等.EB 病毒抗体及其DNA 联合检测在
鼻咽癌筛查和早期诊断中的价值[J]. 检验医学与临床,2015,12
(10):1339-1341.
[4] 王承华,陈漫杰,董玉礼.EB 病毒抗体检测结合鼻内镜检查对鼻
咽癌诊断的意义[J]. 中华全科医学,2011,9(4):552-553.
[5] Marlinda A, Antonius N, Kurniawan, et al. Nasopharyngeal
carcinoma in Indonesia: epidemiology, incidence signs and
symptom at present [J]. Chin J Cancer, 2012,31(4):185-196.
[6] Cao SM, Simons MJ, Qian CN, et al. The prevalence and pre?
vention of nasopharyngeal carcinoma in China [J]. Chin J Can?
cer, 2011,30(2):114-119.
[7] Fachiroh J, Paramita DK, Hariwiyanto B, et al. Single- assay
combination of Epstein- Barr Virus (EBV) EBNA1- and viral
capsid antigen- p18- derived synthetic peptides for measuring
anti- EBV immunoglobulin G (IgG) and IgA antibody levels in
sera from nasopharyngeal carcinoma patients: options for field
screening [J]. J Clin Micrabi, 2006,44(4):1459-1467.
[8] Hsu MM, Hsu WC, Sheen TS, et al. Specific IgA antibodies
to recombinant early and nuclear antigens of Epstein- Barr vi?
rus in nasopharyngeal carcinoma [J]. Clin Otolaryngol Allied
Sci, 2001,26:334-338.
[9] 王盼盼. 季明芳. 鼻咽癌血清学筛查研究进展[J]. 肿瘤研究与临
床,2013,25(8):572-574.
[10] 李福森,侯华新,赵农,等. 尿中单羟酚类物质的测定在鼻咽癌
诊断中的临床意义[J]. 肿瘤研究与临床,2000,12(4):242-243.